VRTX · Verdict

A summary of rules, not a profit forecast — don’t buy just because of a green verdict.

• ▼ P/E 32.5 — expensive for this stock (over 8 y: from 20.5 to 144.1)
• ▼ P/E 32.5 vs peer median 28.1 — more expensive than peers
• ▼ EV/EBITDA 26.6 — expensive for this stock (over 4 y: from 14.6 to 204.6)
• ▼ EV/EBITDA 26.6 vs peer median 20.8 — more expensive than peers
• ▼ FCF yield 2.3% vs peer median 2.7% — more expensive than peers
• ▲ Forward P/E 27.4 is below the current one — earnings growth expected

• ▼ Debt up 126% in 3 y
• ▲ Piotroski 6/8 — strong financial health
• ▲ ROE 24% — high return on equity
• ▼ Net margin fell: 37.2% → 32.9%
• ▲ Debt / equity 0.11 — moderate debt

• ▲ Revenue grows 14.1% per year (5 y)
• ▲ Earnings per share grows 8.3% per year (5 y)
• ▼ Analysts cut the earnings forecast by -1.5% in 90 days

• ▲ Price above SMA200 — long-term uptrend
• ▲ SMA50 above SMA200 — trend up
• ▲ Over a year +33% vs S&P 500 +11% — stronger than the market

• ▼ Earnings in 0 d — the price may move sharply (≈ ±5.6%)
• ▲ Risk/reward 1:5.3 — the target is farther than the stop
• ▼ Volatility 29% per year — much higher than the market (13%)

• ▲ Consensus of 28 analysts — buy
• ▲ Insiders buying over 6 mo

• ▲ S&P 500 above SMA200 — the market is in an uptrend
• ▲ Sector (XLV) above SMA200 — in an uptrend
• ▲ Sector (XLV) over 3 mo is stronger than the market by 11%